Who owns IONIS PHARMACEUTICALS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IONS from SEC Form 13F filings across 464 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 464 institutions disclosed 176.3M shares of IONIS PHARMACEUTICALS INC worth $7.87B — about 106.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
464
13F holders
$7.87B
value, 2026 filers
106.1%
of shares outstanding (176.3M sh)
70
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IONS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 24.7M | $1.10B | 0.0% | 14.9% | +0.4% |
| 2 | Capital World Investors | 21.8M | $972.8M | 0.1% | 13.1% | +0.5% |
| 3 | BlackRock, Inc. | 13.2M | $589.1M | 0.0% | 7.9% | +23.2% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.7M | $344.7M | 0.0% | 4.6% | -1.8% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 7.2M | $322.3M | 0.0% | 4.3% | +0.1% |
| 6 | TWO SIGMA INVESTMENTS, LP | 6.7M | $300.4M | 0.2% | 4% | +7.6% |
| 7 | STATE STREET CORP | 5.7M | $255.0M | 0.0% | 3.4% | +31.7% |
| 8 | ROYAL BANK OF CANADA | 4.8M | $214.8M | 0.0% | 2.9% | -22.2% |
| 9 | CITADEL ADVISORS LLC | 4.0M | $179.8M | 0.0% | 2.4% | +1604.0% |
| 10 | WELLINGTON MANAGEMENT GROUP LLP | 3.4M | $153.2M | 0.0% | 2.1% | -55.2% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 3.3M | $146.4M | 0.0% | 2% | -8.6% |
| 12 | MORGAN STANLEY | 3.1M | $140.4M | 0.0% | 1.9% | +145.3% |
| 13 | T. Rowe Price Investment Management, Inc. | 3.0M | $135.9M | 0.1% | 1.8% | -23.1% |
| 14 | DEERFIELD MANAGEMENT COMPANY, L.P. | 2.7M | $118.8M | 1.8% | 1.6% | +34.4% |
| 15 | WESTFIELD CAPITAL MANAGEMENT CO LP | 2.4M | $107.2M | 0.4% | 1.4% | +56594.2% |
| 16 | Qube Research & Technologies Ltd | 2.0M | $89.1M | 0.1% | 1.2% | +497.6% |
| 17 | Pictet Asset Management Holding SA | 1.9M | $87.2M | 0.1% | 1.2% | +21.7% |
| 18 | Tweedy, Browne Co LLC | 1.8M | $80.1M | 6.5% | 1.1% | -21.4% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.8M | $78.2M | 0.0% | 1.1% | +9.1% |
| 20 | UBS Group AG | 1.5M | $67.3M | 0.0% | 0.9% | +141.4% |
| 21 | Polar Capital Holdings Plc | 1.4M | $64.2M | 0.2% | 0.9% | -1.2% |
| 22 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.4M | $62.8M | 0.0% | 0.8% | -3.3% |
| 23 | Alyeska Investment Group, L.P. | 1.3M | $60.2M | 0.2% | 0.8% | -5.0% |
| 24 | GW&K Investment Management, LLC | 1.3M | $59.9M | 0.5% | 0.8% | +79.6% |
| 25 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.3M | $58.1M | 0.0% | 0.8% | -59.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.